GRETEL SALAZAR: Open Payments
NPI 1821226549 · SPRING, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$301 in 18 payments from 5 companies in 2025. Trend: 2023 $297 · 2024 $713 · 2025 $301
Food & beverage: $301
| Company | Payments | Amount |
|---|---|---|
| Supernus Pharmaceuticals, Inc. | 14 | $126 |
| Teva Pharmaceuticals USA, Inc. | 1 | $116 |
| E.R. Squibb & Sons, L.L.C. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $20 |
| OWP Pharmaceuticals, Inc. | 1 | $17 |
Products named: Qelbree, UZEDY, COBENFY, CAPLYTA, Subvenite.
Industry payments across TX — which companies pay providers there.
